neumind vs CBIT In Hand Uso e estatísticas

Created by experts, neumind is a platform that helps people with neurological conditions such as stroke, brain injury, and concussion, as well as their families and caregivers. neumind combines strategies, cognitive tools and a supportive community to help you live the life you want no matter the challenge. Included are a variety of easy-to-use cognitive tools that can help with memory, planning, attention, fatigue and more. The courses draw on a range of techniques and strategies used in neurorehabilitation to help people better manage their condition. Share stories, tips and support with neumind’s community of members who have all gone through similar experiences. Family members, friends, and other caregivers can also use neumind to provide collective support, and learn how to care for their loved-one’s in a way which supports their long-term independence. neumind is a paid app and requires a monthly subscription to use. Terms of use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
  • Apple App Store
  • Gratuitos
  • Saúde e fitness

Ranking da Loja

- -

- Digital access to support families with childhood concussion / mild brain injury - Access to make ‘in app’ quick and easy referrals for specialist support - Advice, information & support to families and hospital teams - Ability to send support literature and resources direct to a family at home - Access to in-app third-party marketplace suppliers - Digital health intervention
  • Apple App Store
  • Gratuitos
  • Médico

Ranking da Loja

- -

neumind versus CBIT In Hand comparação de classificação

Compare a tendência de classificação de neumind nos últimos 28 dias versus CBIT In Hand

Classificação

Nenhum dado disponível

Comparação da classificação de neumind vs. CBIT In Hand por país

Compare a tendência de classificação de neumind nos últimos 28 dias versus CBIT In Hand

Nenhum dado para exibir

Faça comparações com qualquer site com o nosso teste grátis

Comece agora
neumind VS.
CBIT In Hand

janeiro 3, 2025